| Autor: |
Jose Maria Pereira de Godoy, Gleison Juliano da Silva Russeff, Carolina Hungaro Costa, Debora Yuri Sato, Desirée Franccini Del Frari Silva, Maria de Fatima Guerreiro Godoy, Henrique Jose Pereira de Godoy, Paulo César Espada |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Medicines, Vol 8, Iss 12, p 75 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2305-6320 |
| DOI: |
10.3390/medicines8120075 |
| Popis: |
Background: Current evidence points to a state of hypercoagulability (consequence of hyperinflammation) as an important pathogenic mechanism that contributes to the increase in mortality in cases of COVID-19. The aim of the present study was to investigate the influence of deep-vein thrombosis on mortality patient’s infected with SARS-CoV-2. Method: A clinical trial was conducted involving 200 consecutive patients with COVID-19—100 patients who were positive for deep-vein thrombosis (venous Doppler ultrasound) and 100 who were negative for deep-vein thrombosis at a public hospital. Results: The mortality rate was 67% in the group positive for DVT and 31% in the group negative for DVT. Conclusion: Deep-vein thrombosis is associated with an increase in mortality in patients with COVID-19 and failures can occur with conventional prophylaxis for deep-vein thrombosis. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
